Enzyme News and Research

RSS

Ximelagatran effective for preventing blood clots and stroke

A medication that could simplify anticoagulation therapy, ximelagatran, was found to be as effective as other common therapies for preventing stroke and recurrent blood clots

9 Feb 2005

Inserting corrective genes into the brain to fight Parkinson's disease

An international team of scientists has used gene therapy in two separate studies to renew brain cells and restore normal movements in monkeys and rats with a drug-induced form of Parkinson's disease.

8 Feb 2005

Traditional Indian medicine, herb Salacia oblonga may help treat diabetes

Herbs used in traditional Indian medicine to treat diabetes seems to lower blood sugar and insulin levels in a manner similar to prescription drugs, a new study reports.

8 Feb 2005

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.

7 Feb 2005

Special imaging study shows failing hearts are energy starved

Using magnetic resonance spectroscopy (MRS) for the first time to examine energy production biochemistry in a beating human heart, Johns Hopkins researchers have found substantial energy deficits in failing hearts.

7 Feb 2005

Superbowl molecule shows promise for precision drug delivery

In a development that could one day score a touchdown for better health, chemists in Australia have created a "superbowl" molecule that shows promise for precision drug delivery, according to a recent study in the Journal of the American Chemical Society.

31 Jan 2005

Viagra protects cardiomyocytes against cell death

Virginia Commonwealth University researchers have shown that a widely used drug for treating erectile dysfunction, Viagra, reduces the death of heart cells under heart attack-like conditions in a laboratory model.

31 Jan 2005

$Phenoxodiol gets fast track status for its intended use in patients with hormone-refractory prostate cancer$

Phenoxodiol gets fast track status for its intended use in patients with hormone-refractory prostate cancer

Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).

26 Jan 2005

Exercise may be the easiest for women to decrease their risk of heart disease

For decades, hormone replacement therapy (HRT) was prescribed for postmenopausal women to protect them from cardiovascular disease (CVD). However, results from the Women’s Health Initiative questioned its effectiveness, which has led to more caution in prescribing and using HRT for this purpose.

26 Jan 2005

Evolutionarily ancient enzyme-repair system used to identify type of DNA damage responsible for the onset of skin-tumor development

In a finding that broadens our insight into the cause of certain kinds of UV-induced skin cancer, researchers at Erasmus University Medical Center (Rotterdam, The Netherlands) have employed an evolutionarily ancient enzyme-repair system to identify the principal type of DNA damage responsible for the onset of skin-tumor development.

26 Jan 2005

Drug reviparin reduces the risk of death after heart attack

The drug reviparin (a low molecular weight heparin anticoagulant), when administered to patients with a heart attack, is effective in reducing the risk of death and the risk of a subsequent heart attack, according to a study in the January 26 issue of JAMA.

26 Jan 2005

Plant protein mimics hormone that mitigates diabetes and obesity

A common protein that protects plants from fungal infection mimics the activity of a hormone in mammals that is linked to weight loss and is believed to play a role in mitigating heart disease, obesity and diabetes, according to a team of researchers at Purdue University and several collaborating institutions.

25 Jan 2005

Lack of the enzyme acetyl CoA carboxylase 2 turns fat cells into fat burners

Lack of the enzyme, acetyl CoA carboxylase 2 or ACC2, appears to turn the adipose or fat cells of mice into fat burners, explaining in part why the animals can eat more and weigh less than their normal counterparts, said Baylor College of Medicine researchers.

25 Jan 2005

Over-eating at an early age may stay well into adulthood

Melbourne researchers have found that over-eating at a very young age can have a long-lasting effect on the body and in particular seems to enhance the production of hormones made in fat and involved in metabolism.

24 Jan 2005

Role of ethnicity in nonalcoholic fatty liver disease

The first study to examine nonalcoholic fatty liver disease (NAFLD) among different ethnic and racial groups in the United States finds that Hispanics may be at a higher risk of developing the condition. The study is published in Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience.

19 Jan 2005

Cellular fuel gauge could hold clue to diabetes

A molecule in the body could hold the key to explaining why people who exercise regularly are less likely to have illnesses such as type 2 diabetes.

19 Jan 2005

Simplified approach to the management of patients with an acute coronary syndrome

A simplified approach to the management of patients with an acute coronary syndrome (chest pain at rest or with mild exertion) can help ensure that precise risk-reducing strategies are followed to the letter by doctors and other caregivers of patients with this medical condition, according to a study by Johns Hopkins researchers.

19 Jan 2005

Study provides insight into strategies for telomere-based molecular cancer therapeutics

A new study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.

17 Jan 2005

No to over the counter statin!

Last Friday an FDA expert panel voted overwhelmingly against the over-the-counter sale of Merck's cholesterol lowering drug Mevacor (lovastatin). Mevacor is one of a number of drugs known as "statins" which are widely considered to be the most effective drugs for the treatment of high cholesterol. Statins work by inhibiting a liver enzyme used in the manufacture of cholesterol.

17 Jan 2005

Patient drawings important diagnostic tool for heart attack recovery

Simple drawings by heart attack victims of what they believe has happened to their heart may be an important diagnostic tool to aid their recovery, research at The University of Auckland has shown.

17 Jan 2005

Enzyme News and Research

Ximelagatran effective for preventing blood clots and stroke

Inserting corrective genes into the brain to fight Parkinson's disease

Traditional Indian medicine, herb Salacia oblonga may help treat diabetes

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

Special imaging study shows failing hearts are energy starved

Superbowl molecule shows promise for precision drug delivery

Viagra protects cardiomyocytes against cell death

Phenoxodiol gets fast track status for its intended use in patients with hormone-refractory prostate cancer

Exercise may be the easiest for women to decrease their risk of heart disease

Evolutionarily ancient enzyme-repair system used to identify type of DNA damage responsible for the onset of skin-tumor development

Drug reviparin reduces the risk of death after heart attack

Plant protein mimics hormone that mitigates diabetes and obesity

Lack of the enzyme acetyl CoA carboxylase 2 turns fat cells into fat burners

Over-eating at an early age may stay well into adulthood

Role of ethnicity in nonalcoholic fatty liver disease

Cellular fuel gauge could hold clue to diabetes

Simplified approach to the management of patients with an acute coronary syndrome

Study provides insight into strategies for telomere-based molecular cancer therapeutics

No to over the counter statin!

Patient drawings important diagnostic tool for heart attack recovery

Biochemistry eBook

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest Life Science News